Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Iron Deficiency
100%
Preterm Infants
35%
Iron Status
34%
Iron Deficient
33%
Anemia
26%
Neurodevelopment
24%
Brain Development
24%
Rat Hippocampus
20%
Iron Deficiency Anemia
19%
Choline
18%
Neonatal Iron Deficiency
17%
Iron Supplementation
17%
Hippocampus
17%
Gestational Age
16%
Newborn Infant
15%
Perinatal Iron Deficiency
14%
Fetal Alcohol Spectrum Disorder
13%
Premature Infant
13%
Choline Supplementation
12%
Ferritin
12%
Brain Iron
12%
Transferrin Receptor 1 (TfR1)
11%
Recognition Memory
11%
Erythropoietin
11%
Adult Rats
11%
Neonate
11%
During Pregnancy
10%
Serum Ferritin
10%
Birth Weight
10%
Iron Stores
9%
Neurodevelopmental Outcome
9%
Postnatal Day
9%
Randomized Clinical Trial
8%
Phlebotomy
8%
Gene Expression
8%
Iron Treatment
8%
Adulthood
8%
Infant of Diabetic Mother
8%
Diabetic Pregnancy
7%
Hippocampal Neurons
7%
Young children
7%
Pregnant Women
7%
Bronchopulmonary Dysplasia
7%
Hepatoblastoma
7%
Children's Oncology Group
7%
Corrected Age
7%
Iron Concentration
6%
Event-related Potentials
6%
Iron Repletion
6%
Illness
6%
Medicine and Dentistry
Iron Deficiency
67%
Prematurity
27%
Supplementation
25%
Nerve Cell Differentiation
20%
Anemia
20%
Gestational Age
19%
Nutrition
19%
Newborn Infant
18%
Hippocampus
17%
Hypochromic Anemia
17%
Ferritin
16%
Neonatal Infant
15%
Diseases
15%
Hemoglobins
13%
Iron Storage
13%
Birth Weight
11%
Iron Supplement
11%
Low Birth Weight
11%
Arm
10%
Choline
10%
Biological Marker
9%
Oral
9%
Lung Dysplasia
9%
Maternal Diabetes Mellitus
9%
Very Low Birth Weight
9%
Human Milk
8%
Randomized Clinical Trials
8%
Erythropoietin
8%
Brain Development
7%
Malaria
7%
Serum Iron
7%
Inflammation
7%
Oncology
7%
Hepatoblastoma
7%
Neonates
6%
Placebo
6%
Single Drug Dose
6%
Infancy
6%
Offspring
6%
Adolescence
6%
Hypoxia
5%
Bayley Scales of Infant Development
5%
Brain Injury
5%
Fetal Alcohol Syndrome
5%
Event-Related Potential
5%
Prevalence
5%
Pediatrics
5%
Intrauterine Growth Retardation
5%
Erythrocyte Transfusion
5%
Growth Disorder
5%